Details of Disease

General Information of Disease (ID: DISJMF88)

• Disease Name: Head and body lice
• Disease Class: 1G00: Pediculosis
• Disease Hierarchy:
  DIS01GPL: Grass pollen hypersensitivity
  DISJMF88: Head and body lice
• ICD Code:
  ICD-11: ICD-11: 1G00.0
  ICD-10: ICD-10: B85.0
  ICD-9: ICD-9: 132
  Expand ICD-11: '1G00.0
  Expand ICD-10: 'B85.0
  Expand ICD-9: 132

Drug-Interaction Atlas (DIA) of This Disease

This Disease is Treated as An Indication in 4 Approved Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
Abametapir	DM2RX0I	Approved	Small molecular drug	[1]
Benzyl alcohol	DMBVYDI	Approved	Small molecular drug	[2]
Resultz	DM0RPZF	Approved	NA	[3]
Spinosad	DM0BQRS	Approved	Small molecular drug	[4]

This Disease is Treated as An Indication in 1 Preclinical Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
DFD-11	DMHXVN1	Application submitted	NA	[5]

Molecular Interaction Atlas (MIA) of This Disease

References

• [1] Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health Human Services. 2020
• [2] Hughes B: 2009 FDA drug approvals. Nat Rev Drug Discov. 2010 Feb;9(2):89-92.
• [3] Clinical pipeline report, company report or official report of Piedmont pharmaceuticals.
• [4] 2011 FDA drug approvals. Nat Rev Drug Discov. 2012 Feb 1;11(2):91-4.
• [5] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)